山东大学耳鼻喉眼学报 ›› 2016, Vol. 30 ›› Issue (4): 50-55.doi: 10.6040/j.issn.1673-3770.0.2016.292

• 变应性鼻炎 • 上一篇    下一篇

尘螨疫苗皮下注射治疗变应性鼻炎的疗效和安全性评估

屠燕怡1,2,史丽1,2,赵莉1,2,金鹏1,2,訾晓雪1,2,李昂1,2,金义炫1,2,郅莉莉3   

  1. 1.山东大学医学院, 山东 济南 250012;
    2.山东大学第二医院耳鼻喉科, 山东 济南 250033;
    3.淄博市中心医院耳鼻喉科, 山东 淄博 255031
  • 收稿日期:2016-06-27 出版日期:2016-08-16 发布日期:2016-08-16
  • 通讯作者: 郅莉莉. E-mail:8wy3390410@163.com E-mail:tuyanyi001@126.co
  • 作者简介:屠燕怡. E-mail:tuyanyi001@126.co
  • 基金资助:
    国家自然科学基金(81441028);山东省科技发展计划项目(2010G0020258)

Efficacy and safety of subcutaneous immunotherapy with house dust mite extract for allergic rhinitis.

TU Yanyi1,2, SHI Li1,2, ZHAO Li1,2, JIN Peng1,2, ZI Xiaoxue1,2, LI Ang1,2, JIN Yixuan1,2, ZHI Lili   

  1. 1. School of Medicine, Shandong University, Jinan 250012, Shandong, China;2. Department of Otolaryngology, The Second Hospital of Shandong University, Jinan 250033, Shandong, China;3. Department of Otolaryngology, Central Hospital of Zibo, Zibo 255031, Shandong, China
  • Received:2016-06-27 Online:2016-08-16 Published:2016-08-16

PDF (PC)

1735

被引次数

2

摘要： 目的 本研究旨在通过使用标准化尘螨疫苗对变应性鼻炎伴或不伴支气管哮喘的患者进行2年皮下免疫治疗,探讨尘螨皮下免疫治疗的疗效和安全性。 方法 纳入58例对尘螨过敏(单一过敏35例,多重过敏23例)的变应性鼻炎患者,伴或不伴支气管哮喘。在治疗前与治疗后的第6、12、24个月,分析症状评分、视觉模拟量表评分和生活质量评分的变化,观察记录发生的局部及全身不良反应。 结果 与治疗前相比,鼻部症状和哮喘症状评分在治疗6个月后均显著降低(P<0.05),并在2年治疗期内呈持续性下降。治疗2年后,单一过敏患者和多重过敏患者的症状评分差异无统计学意义(P>0.05)。皮下免疫治疗6、12、24个月后,鼻炎和哮喘的相关生活质量也得到了显著改善(P<0.05)。发生的不良反应以局部反应为主,未出现严重不良反应。 结论 皮下免疫治疗是针对尘螨引起的变应性鼻炎的一种安全、有效的治疗方法,对于变应性鼻炎合并支气管哮喘的患者,也能取得显著的疗效。

关键词: 免疫治疗,皮下, 哮喘, 疗效, 鼻炎,变应性, 屋尘螨

Abstract: Objective Investigate the efficacy and safety of 2-year subcutaneous immunotherapy(SCIT)with HDM extract for allergic rhinitis with/without asthma. Methods A total of 58 patients with HDM-induced AR(35 sensitized to HDM only and 23 sensitized to HDM and other allergens simultaneously)with/without asthma were included. Symptom scores, visual analogue scale and quality of life were assessed before and after 6, 12 and 24 months of SCIT. Local and systemic adverse events were recorded for safety. Results Symptom scores decreased significantly(P<0.05)after 6 months of immunotherapy for both AR and asthma, and continued to decline until the end of the treatment. There was no statistical difference(P>0.05)between monosensitized patients and polysensitized patients in symptom scores after 2-year SCIT. Marked improvements(P<0.05)in quality of life were also observed after 6, 12 and 24 months of SCIT. Most side-effects were local reactions, no serious adverse event was reported during the treatment. Conclusion For AR patients, especially accompanied with asthma, SCIT is an effective and safe treatment.

Key words: Subcutaneous immunotherapy, House dust mite, Efficacy, Asthma, Allergic rhinitis

中图分类号: 

  • R765.21
[1] 韩德民,张罗,黄丹,等.我国11个城市变应性鼻炎自报患病率调查[J].中华耳鼻咽喉头颈外科杂志,2007,42(5):378-384. HAN Demin, ZHANG Luo, HUANG Dan, et al. Self-reported prevalence of allergic rhinitis in eleven cities in China[J]. Chin J Otorhinolaryngol Head Neck Surgery, 2007, 42(5):378-384.
[2] Law M, Morris JK, Wald N, et al: Changes in atopy over a quarter of a century, based on cross-sectional data at three time periods[J]. BMJ, 2005, 330(7501):1187-1188.
[3] Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhinitis and its impact on asthma(ARIA)2008 update[J]. Allergy, 2008, 63(Suppl 86):8-160.
[4] Pichler C E, Marquardsen A, Sparholt S, et al. Specific immunotherapy with Dermatophagoides pteronyssinus and D. farinae results in decreased bronchial hyperreactivity[J]. Allergy, 1997, 52(3):274-283.
[5] Noon L. Prophylactic inoculation against hay fever[J]. Int Arch Allergy Appl Immunol, 1953, 4:285-288.
[6] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 变应性鼻炎诊断和治疗指南(2015年,天津)[J]. 中华耳鼻咽喉头颈外科杂志,2016,51(1):6-24.
[7] Canonica G W. A survey of the burden of allergic rhinitis in Europe[J]. Allergy, 2007, 62(Suppl):17-25.
[8] 中华耳鼻咽喉头颈外科杂志编委会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 变应性鼻炎诊断和治疗指南(2009年,武夷山)[J]. 中华耳鼻咽喉头颈外科杂志,2009,44(12):977-978.
[9] Juniper E F. Measuring health-related quality of life in rhinitis[J]. J Allergy Clin Immunol, 1997, 99(2):742-749.
[10] Juniper E F, Guyatt G H, Ferrie P J, et al. Measuring quality of life in asthma[J]. Am Rev Resp Dis, 1993, 147(4):832-838.
[11] Cox L, Wallace D. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual[J]. Immunol Allergy Clin North Am, 2011, 31(3):561-599.
[12] 中华耳鼻咽喉头颈外科杂志编委会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 变应性鼻炎特异性免疫治疗专家共识[J]. 中华耳鼻咽喉头颈外科杂志,2011,46(12):976-980.
[13] Sporik R, Holgate S T, Platts-Mills T A, et al. Exposure to house-dust mite allergen(Der pI)and the development of asthma in childhood. A prospective study[J]. N Engl J Med, 1990, 323(8):502-507.
[14] 中华耳鼻咽喉头颈外科杂志编辑委员会,中华医学会耳鼻咽喉科学分会.变应性鼻炎的诊治原则和推荐方案(2004年,兰州)[J].中华耳鼻咽喉头颈外科杂志,2005,40(3):166-167.
[15] Bousquet J, Braquemond P, Feinberg J, et al. Specific IgE response before and after rush immunotherapy with a standardized allergen or allergoid in grass pollen allergy[J]. Ann Allergy, 1986, 56(6):456-459.
[16] 孙劲旅, 陈军, 张宏誉. 尘螨过敏原的交叉反应性[J]. 昆虫学报, 2006, 49(4): 695-699. SUN Jinlu, CHEN Jun, ZHANG Hongyu. Allergenic cross-reactivity between house dust mites and other mites[J]. Acta Entomologica Sinica, 2006, 49(4):695-699.
[17] Chen J, Li B, Zhao Y, et al. A prospective multicenter study of systemic reactions in standardized specific immunotherapy for allergic rhinitis in China[J]. Am J Rrhinol Allergy, 2014, 28(1):e40-e44.
[1] 方璐, 雷玉丹, 王华. 环孢素滴眼液联合玻璃酸钠滴眼液治疗干眼临床效果的Meta分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 65-73.
[2] 雷玉丹,方璐,陈健,彭昌福. 托珠单抗治疗激素抵抗或不耐受的中重度甲状腺相关性眼病临床疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 54-67.
[3] 朱明琼,李征,刘茹,田涛,彭婧利,吕倩怡,谭华霞. 基于OCT/OCTA的AI筛查系统在抗VEGF治疗糖尿病性黄斑水肿患者效果评价中的应用[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 68-73.
[4] 孙庆祝,沈健,陈星,吴雁冰,曾论. 代谢指标在预测糖尿病性黄斑水肿患者雷珠单抗疗效中的作用[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 74-81.
[5] 刘怡君,谷悦,官大宇,杨玉成,沈暘. 翼管神经切断术在难治性变应性鼻炎中远期临床疗效和安全性[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 42-48.
[6] 孙春晓,王文晴,岳田,刘济生. 高低累积顺铂剂量同步放化疗治疗鼻咽癌的疗效分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 31-41.
[7] 郑泽皓,魏佳俐,刘嘉涛,周玉麒,孙文婷,李雨轩,白鹏. 特定部位针刺法治疗突发性聋的疗效及安全性评价:一项系统综述和网状Meta分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 114-127.
[8] 邹嵩,许保源,张金星,陈巧婷,李健祥. ABCLOVE嗓音训练法对声带良性增生性病变手术患者嗓音功能的影响[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 32-37.
[9] 王鑫,原晶晶,郝鹏鹏,闫占峰,刘建华,钟利群,刘思溟,吴薇,赵晓阳,张莹. 中药复方治疗突发性聋的疗效和可能机制:一项结合网络药理学研究的回顾性临床分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 6-17.
[10] 曹正勇,李小波. 慢性鼻-鼻窦炎合并哮喘术后短程局部使用糖皮质激素辅助治疗的安全性和有效性[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 43-50.
[11] 周静琳,李金香,曾琦. 577 nm阈值下微脉冲激光联合抗VEGF药物治疗难治性糖尿病性黄斑水肿的疗效观察[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 18-25.
[12] 崇维琨,王娟. 联合应用奥马珠单抗在儿童中重度变应性哮喘合并慢性鼻窦炎中的疗效观察[J]. 山东大学耳鼻喉眼学报, 2024, 38(1): 21-26.
[13] 孙汐文,骆春雨,李志鹏,张维天. 铁死亡在呼吸道炎症性疾病中的作用及研究进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(6): 24-32.
[14] 徐宏鸣,范文焱,浦诗磊,李晓艳. 儿童上颌窦后鼻孔息肉36例临床资料分析[J]. 山东大学耳鼻喉眼学报, 2023, 37(6): 159-163.
[15] 王晓嫒,张欠欠,程翔宇,李志鹏,张维天,叶海波. 翼管神经切断术治疗2型慢性鼻窦炎伴过敏性鼻炎的临床疗效分析[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 42-49.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发